Precigen (PGEN) Earnings Analysis

Precigen (PGEN) has no confirmed upcoming earnings date. Last quarter (2026-03-25) it beat with EPS -0.01 USD vs -0.1 USD est (+90%). It has beaten estimates in 2/5 recent quarters (40%). Trailing P/E -4.15.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does PGEN next report earnings?

No confirmed upcoming earnings date is currently scheduled for PGEN. This page updates as the calendar is published.

PGEN earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-25-0.01 USD-0.1 USD+90%Beat
2025-11-13-0.11 USD-0.08 USD-37.5%Miss
2025-03-19-0.04 USD-0.06 USD+33.3%Beat
2024-11-14-0.09 USD-0.08 USD-12.5%Miss
2024-08-14-0.1 USD-0.09 USD-11.1%Miss

Beat rate: 2/5 (40%) over reported quarters with consensus data.

PGEN valuation and analyst view

Trailing P/E-4.15
Trailing EPS-0.65313 USD
Price / book82.29
Dividend yield0.00%
Market cap1.58B
Analyst consensusBuy (11 buy / 4 hold / 1 sell)
Avg price target12.5 USD

Related research pages

Frequently asked questions

When is Precigen (PGEN)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for PGEN. This page updates as the calendar is published.

Did PGEN beat earnings last quarter?

In its 2026-03-25 report, PGEN posted EPS of -0.01 USD versus a -0.1 USD estimate — a beat of 90%.

What is PGEN's earnings track record?

Over the last 5 reported quarters with consensus data, PGEN beat estimates 2 times (40%).

What is PGEN's current P/E ratio and EPS?

PGEN trades at a trailing P/E of -4.15 on trailing EPS of -0.653133212790384 USD.

What do analysts rate PGEN?

Analyst consensus is "Buy" across 16 ratings (0 strong buy, 11 buy, 4 hold, 1 sell, 0 strong sell). Average 12-month price target: 12.5 USD.